These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 7723950)

  • 1. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
    Gore JM; Sloan M; Price TR; Randall AM; Bovill E; Collen D; Forman S; Knatterud GL; Sopko G; Terrin ML
    Circulation; 1991 Feb; 83(2):448-59. PubMed ID: 1899364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.
    Kase CS; Pessin MS; Zivin JA; del Zoppo GJ; Furlan AJ; Buckley JW; Snipes RG; LittleJohn JK
    Am J Med; 1992 Apr; 92(4):384-90. PubMed ID: 1558085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience.
    Sloan MA; Price TR; Terrin ML; Forman S; Gore JM; Chaitman BR; Hodges M; Mueller H; Rogers WJ; Knatterud GL; Braunwald E
    Stroke; 1997 Jun; 28(6):1107-14. PubMed ID: 9183334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Bovill EG; Terrin ML; Stump DC; Berke AD; Frederick M; Collen D; Feit F; Gore JM; Hillis LD; Lambrew CT
    Ann Intern Med; 1991 Aug; 115(4):256-65. PubMed ID: 1906692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis.
    Kase CS; O'Neal AM; Fisher M; Girgis GN; Ordia JI
    Ann Intern Med; 1990 Jan; 112(1):17-21. PubMed ID: 2104561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment.
    Pendlebury WW; Iole ED; Tracy RP; Dill BA
    Ann Neurol; 1991 Feb; 29(2):210-3. PubMed ID: 1901466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.
    Da Silva VF; Bormanis J
    Neurosurgery; 1992 Jun; 30(6):943-5. PubMed ID: 1614602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
    Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
    J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage.
    Reuter B; Grudzenski S; Chatzikonstantinou E; Meairs S; Ebert A; Heiler P; Schad LR; Staufenbiel M; Hennerici MG; Fatar M
    Stroke; 2014 Aug; 45(8):2411-6. PubMed ID: 25005438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Gebel JM; Sila CA; Sloan MA; Granger CB; Mahaffey KW; Weisenberger J; Green CL; White HD; Gore JM; Weaver WD; Califf RM; Topol EJ
    Stroke; 1998 Mar; 29(3):563-9. PubMed ID: 9506593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction.
    Bleich SD; Nichols TC; Schumacher RR; Cooke DH; Tate DA; Teichman SL
    Am J Cardiol; 1990 Dec; 66(20):1412-7. PubMed ID: 2123602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
    Cannon CP; Gibson CM; McCabe CH; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Giugliano RP; Frey M; Mueller HS; Steingart RM; Weaver WD; Van de Werf F; Braunwald E
    Circulation; 1998 Dec 22-29; 98(25):2805-14. PubMed ID: 9860780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators.
    Chaitman BR; Thompson B; Wittry MD; Stump D; Hamilton WP; Hillis LD; Dwyer JG; Solomon RE; Knatterud GL
    J Am Coll Cardiol; 1989 Nov; 14(5):1159-65. PubMed ID: 2509528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral hematoma related to thrombolysis for myocardial infarction.
    Kaufman HH; McAllister P; Taylor H; Schmidt S
    Neurosurgery; 1993 Nov; 33(5):898-900; discussion 900-1. PubMed ID: 8264890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
    Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
    Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation.
    Tountopoulou A; Ahl B; Weissenborn K; Becker H; Goetz F
    Neuroradiology; 2008 Jan; 50(1):75-83. PubMed ID: 17917723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.